1-3 of 3
Nirmish Singla
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma

Available to Purchase
Aditi Mulgaonkar, Roy Elias, Layton Woolford, Bing Guan, Kien Nham, Payal Kapur, Alana Christie, Vanina T. Tcheuyap, Nirmish Singla, I. Alex Bowman, Christina Stevens, Guiyang Hao, James Brugarolas, Xiankai Sun
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (22): 4907–4916.
https://doi.org/10.1158/1078-0432.CCR-22-1547
Published: 14 November 2022
View articletitled, ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma
Open the PDF for ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables In Vivo Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract B21: PTRF promotes cell survival and predicts disease progression in upper tract urothelial carcinoma

Free
Hsin-Chih Yeh, Nirmish Singla, Elizabeth Hernandez, Vandana Panwar, Vitaly Margulis, Payal Kapur, Shahrokh F. Shariat, Wen-Jeng Wu, Jer-Tsong Hsieh
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (15_Supplement): B21.
https://doi.org/10.1158/1557-3265.BLADDER19-B21
Published: 03 August 2020
View articletitled, Abstract B21: PTRF promotes cell survival and predicts disease progression in upper tract urothelial carcinoma
Journal Articles

HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma

Available to Purchase
Kevin D. Courtney, Yuanqing Ma, Alberto Diaz de Leon, Alana Christie, Zhiqun Xie, Layton Woolford, Nirmish Singla, Allison Joyce, Haley Hill, Ananth J. Madhuranthakam, Qing Yuan, Yin Xi, Yue Zhang, Jenny Chang, Oluwatomilade Fatunde, Yull Arriaga, Arthur E. Frankel, Sanjeeva Kalva, Song Zhang, Tiffani McKenzie, Oscar Reig Torras, Robert A. Figlin, Brian I. Rini, Renée M. McKay, Payal Kapur, Tao Wang, Ivan Pedrosa, James Brugarolas
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (4): 793–803.
https://doi.org/10.1158/1078-0432.CCR-19-1459
Published: 14 February 2020
View articletitled, HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma
Open the PDF for HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor, in Patients with Clear Cell Renal Cell Carcinoma in another window
Includes: Supplementary data